Figure 2

Pretreatment ROMs levels (U. CARR) in patients with non-small cell lung cancer classified as responders (complete response/partial response) and non-responders (stable disease/progressive disease). Data are expressed as means ± SD. No significant difference in ROMs level was observed between responders and non-responders (p = 0.14, unpaired t-test).